Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,153,968
+$130,113 QoQ
Shares Held
9,414
-3.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#172
of 341 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Derivatives in PTGX
reported options exposure · as of Dec 31, 2025CallValue
$3,554,738
CallShares
40,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. PTGX ranks #30 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in PTGX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,153,968 | 9,414 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,023,855 | 9,714 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,046,025 | 46,325 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $3,554,738 | 40,700 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $1,200,257 | 18,068 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,980,213 | 35,828 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,060,136 | 42,600 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $3,155,199 | 65,244 | Shares | Sole | 2025-05-15 | |
| 2023-06-30 | $1,491,480 | 54,000 | Call | Sole | 2023-08-14 | |
| 2022-03-31 | $1,938,752 | 81,873 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,463,681 | 130,517 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $896,971 | 19,986 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,284,096 | 49,579 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $772,954 | 38,341 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $453,872 | 23,216 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $871,679 | 49,359 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||